By Sheri Kasprzak
New York, Jan. 23 - Amarin Corp. plc said it received a definitive agreement for a $2 million private placement.
Tony Ryan, a director of Ryanair Holdings and one of Amarin's current shareholders, agreed to buy 800,000 shares at $2.50 each.
Ryan will receive warrants for 280,000 shares, exercisable at $3.06 each.
London-based Amarin is a biopharmaceutical company focused on developing treatments for central nervous system disorders.
| Issuer: | Amarin Corp. plc
|
| Issue: | Stock
|
| Amount: | $2 million
|
| Shares: | 800,000
|
| Price: | $2.50
|
| Warrants: | For 280,000 shares
|
| Warrant strike price: | $3.06
|
| Investor: | Tony Ryan
|
| Announcement date: | Jan. 23
|
| Stock symbol: | Nasdaq: AMRN
|
| Stock price: | $2.76 at close Jan. 23
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
